Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics

References

• Srisuk P, Thongnopnua P, Raktanonchai U, Kanokpanont S. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int J Pharm 2012;427:426–34
   PubMed Web of Science ®Google Scholar
• Lin YK, Huang ZR, Zhuo RZ, Fang JY. Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine 2010;5:117–28
   PubMed Web of Science ®Google Scholar
• Longo-Sorbello GS, Bertino JR. Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica 2001;86:121–7
   Google Scholar
• Yang F, Kamiya N, Goto M. Transdermal delivery of the anti-rheumatic agent methotrexate using a solid-in-oil nanocarrier. Eur J Pharm Biopharm 2012;82:158–63
   PubMed Web of Science ®Google Scholar
• Lee SW, Kim JH, Park MC, et al. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery. Biomaterials 2012;33:1563–72
   PubMed Web of Science ®Google Scholar
• Ali MF, Salah M, Rafea M, Saleh N. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit 2008;14:PI66–74
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Hamishehkar H. Enhancing percutaneous delivery of methotrexate using different types of surfactants. Colloids Surf B Biointerfaces 2011;82:422–6
   PubMed Web of Science ®Google Scholar
• Samah NA, Williams N, Heard CM. Nanogel particulates located within diffusion cell receptor phases following topical application demonstrates uptake into and migration across skin. Int J Pharm 2010;401:72–8
   PubMed Web of Science ®Google Scholar
• Singka GS, Samah NA, Zulfakar MH, et al. Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel. Eur J Pharm Biopharm 2010;76:275–81
   PubMed Web of Science ®Google Scholar
• Alvarez-Figueroa MJ, Delgado-Charro MB, Blanco-Mendez J. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm 2001;212:101–7
   PubMed Web of Science ®Google Scholar
• Sharma A, Arora S. Formulation and in vitro evaluation of ufasomes for dermal administration of methotrexate. ISRN Pharm 2012;2012:873653 . doi: http://dx.doi.org/10.5402/2012/873653
   PubMedGoogle Scholar
• Farkas E, Zelko R, Torok G, et al. Influence of chlorhexidine species on the liquid crystalline structure of vehicle. Int J Pharm 2001;213:1–5
   PubMed Web of Science ®Google Scholar
• Bagwe RP, Kanicky JR, Palla BJ, et al. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carrier Syst 2001;18:77–140
   PubMed Web of Science ®Google Scholar
• Agarwal R, Katare OP, Kumar B. A novel inter and intra multilamellar vesicular composition. Australia PatentAU2006225991;2010
   Google Scholar
• Menting SP, Dekker PM, Limpens J, et al. Methotrexate dosing regimen for plaque-type psoriasis: a systematic review of the use of test-dose, start-dose, dosing scheme, dose adjustments, maximum dose and folic acid supplementation. Acta Derm Venereol 2015. [Epub ahead of print]. Doi: 10.2340/00015555-2081
   PubMed Web of Science ®Google Scholar
• AbuHilal M, Ho N. Successful treatment of severe psoriasis in an adolescent with ustekinumab. Pediatr Dermatol 2015;32:377–80
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Cuppo F, Reynaers H, et al. Light scattering measurements on microemulsions: estimation of droplet sizes. Int J Pharm 2006;312:187–95
   PubMed Web of Science ®Google Scholar
• Garg NK, Dwivedi P, Campbell C, Tyagi RK. Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention. Eur J Pharm Sci 2012;47:1006–14
   PubMed Web of Science ®Google Scholar
• Jain AK, Jain A, Garg NK, et al. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment. Colloids Surf B Biointerfaces 2014;121C:222–9
   Web of Science ®Google Scholar
• Raza K, Singh B, Lohan S, et al. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity. Int J Pharm 2013;456:65–72
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Weng T, et al. A study of microemulsion systems for transdermal delivery of triptolide. J Control Release 2004;98:427–36
   PubMed Web of Science ®Google Scholar
• El-Marhraby GM, Williams AC, Barry BW. Skin delivery of 5-Fluorouracil from ultradeformable and standard liposomes in vitro. J Pharm Pharmacol 2001;53:1069–77
   PubMed Web of Science ®Google Scholar
• Raza K, Singh B, Mahajan A, et al. Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. J Drug Target 2011;19:293–302
   PubMed Web of Science ®Google Scholar
• van der Fits L, Mourits S, Voerman JS, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol 2009;182:5836–45
   PubMed Web of Science ®Google Scholar
• El Malki K, Karbach SH, Huppert J, et al. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling. J Invest Dermatol 2013;133:441–51
   PubMed Web of Science ®Google Scholar
• Papp K, Cather JC, Rosoph L, et al. Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet 2012;380:738–46
   PubMed Web of Science ®Google Scholar
• Kim H, Kim M, Kim H, et al. Anti-inflammatory activities of Dictamnus dasycarpus Turcz., root bark on allergic contact dermatitis induced by dinitrofluorobenzene in mice. J Ethnopharmacol 2013;149:471–7
   PubMed Web of Science ®Google Scholar
• Zhu W, Yu A, Wang W, et al. Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm 2008;360:184–90
   PubMed Web of Science ®Google Scholar
• Neubert RH, Schmalfuss U, Wolf R, Wohlrab WA. Microemulsions as colloidal vehicle systems for dermal drug delivery. Part V: microemulsions without and with glycolipid as penetration enhancer. J Pharm Sci 2005;94:821–7
   PubMed Web of Science ®Google Scholar
• Huri MFD, Ng SF, Zulfakar MH. Fish oil-based oleogels: physicochemicals characterisation and in vitro release of betamethasone dipropionate. Int J Pharm Pharm Sci 2013;5:458–67
   Google Scholar
• Jones DS, Woolfson AD, Brown AF. Textural analysis and flow rheometry of novel, bioadhesive antimicrobial oral gels. Pharm Res 1997;14:450–7
   PubMed Web of Science ®Google Scholar
• Alvarez-Figueroa MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm 2001;215:57–65
   PubMed Web of Science ®Google Scholar
• Anderson BC, Pandit NK, Mallapragada SK. Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. J Control Release 2001;70:157–67
   PubMed Web of Science ®Google Scholar
• Nair V, Panchagnula R. Poloxamer gel as vehicle for transdermal iontophoretic delivery of arginine vasopressin: evaluation of in vivo performance in rats. Pharmacol Res 2003;47:555–62
   PubMed Web of Science ®Google Scholar
• El Laithy HM, El-Shaboury KM. The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS PharmSciTech 2002;3:E35
   PubMedGoogle Scholar
• Huttenrauch R, Fricke S. Dependence of the release of active principles from ointment bases upon the degree of order of the solid phase. Pharmazie 1979;34:437–8
   Web of Science ®Google Scholar
• Thachrodi D, Panduranga RK. Transdermal absorption of nifedipine from microemulsions of lipophilic skin penetration enhancers. Int J Pharm 1994;111:235–40
   Web of Science ®Google Scholar
• Osborne DW, Ward AJI, O'Neill KJ. Microemulsions as topical drug delivery vehicles: in vitro transdermal studies of a model hydrophilic drug. J Pharm Pharmacol 1991;43:451–4
   Web of Science ®Google Scholar
• Dubey V, Mishra D, Dutta T, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123:148–54
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Urtti A, Valjakka-Koskela R, et al. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999;7:279–86
   PubMed Web of Science ®Google Scholar
• Schwartz PM, Milstone LM. Dipyridamole potentiates the growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro. J Invest Dermatol 1989;93:523–7
   PubMed Web of Science ®Google Scholar
• Sebok B, Bonnekoh B, Geisel J, Mahrle G. Antiproliferative and cytotoxic profiles of antipsoriatic fumaric acid derivatives in keratinocyte cultures. Eur J Pharmacol 1994;270:79–87
   PubMed Web of Science ®Google Scholar
• Rajan N, Langtry JA. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermatol 2006;31:140–1
   PubMed Web of Science ®Google Scholar
• Yamaki K, Uchida H, Harada Y, et al. Effect of methotrexate on Th1 and Th2 immune responses in mice. J Pharm Pharmacol 2003;55:1661–6
   PubMed Web of Science ®Google Scholar
• Bosman B. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 1994;7:324–34
   PubMedGoogle Scholar
• Draize J, Woodard G, Calvery H. Methods for the study of irritation and toxicity of substance applied to the skin and mucous membranes. J Pharmacol Exp Ther 1944;82:377–90
   Web of Science ®Google Scholar
• Corsini E, Galli CL. Cytokines and irritant contact dermatitis. Toxicol Lett 1998;102–103:277–82
   PubMed Web of Science ®Google Scholar
• Stratton LP, Dong A, Manning MC, Carpenter JF. Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel. J Pharm Sci 1997;86:1006–10
   PubMed Web of Science ®Google Scholar